Alphabet

ESOLONG®

Indication: 

Adults: ∙ Antisecretory therapy when it is impossible to use the oral route of administration: - gastroesophageal reflux disease in patients with esophagitis and / or severe reflux symptoms; - treatment of gastric ulcers associated with the treatment of nonsteroidal anti-inflammatory drugs (NSAIDs); - prevention of gastric and duodenal ulcers associated with NSAID therapy in at-risk patients. ∙ Short-term maintenance of hemostasis and prevention of recurrent bleeding in patients after endoscopic treatment of acute bleeding due to the ulcer of stomach or duodenum. Children from 1 to 18 years: ∙ Antisecretory therapy when it is impossible to use the oral route of administration: - gastroesophageal reflux disease (GERD) in patients with erosive reflux esophagitis and / or severe reflux symptoms.  

EASYDO

Indication: 

Recommended in cases The presence of an inflammatory process in the intestinal mucosa against constipation (microscopic colitis, diverticular bowel disease, and so on) Necessity to avoid pressure, after the postponed operative interventions Constipation: - Functional and other genesis (irritable bowel syndrome, dolichosigmoid, diabetic colonopathy and t p) - With manifestations of intestinal discomfort and a decrease in the motor function of the intestine (hypotonic constipation, in h in elderly people)  

Ezolong®-20/ Ezolong®-40

Indication: 

The drug is used to treat gastroesophageal reflux disease; Erosive reflux esophagitis; For long-term maintenance therapy with treated esophagitis to prevent relapse; For the healing of duodenal ulcer, associated with Helicobacter pylori; Caused by therapy with NSAIDs.